Activated SOX9+ Renal Epithelial Cells Promote Kidney Repair Through Secreting Factors
Overview
Affiliations
A broad spectrum of lethal kidney diseases involves the irreversible destruction of the tubular structures, leading to renal function loss. Following injury, a spectrum of tissue-resident epithelial stem/progenitor cells are known to be activated and then differentiate into mature renal cells to replace the damaged renal epithelium. Here, however, we reported an alternative way that tissue-resident cells could be activated to secrete multiple factors to promote organ repair. At single-cell resolution, we showed that the resident SOX9+ renal epithelial cells (RECs) could expand in the acutely injured kidney of both mouse and human. Compared to other cells, the SOX9+ RECs overexpressed much more secretion related genes, whose functions were linked to kidney repair pathways. We also obtained long-term, feeder-free cultured SOX9+ RECs from human urine and analysed their secretory profile at both transcriptional and proteomic levels. Engraftment of cultured human SOX9+ RECs or injection of its conditional medium facilitated the regeneration of renal tubular and glomerular epithelium, probably through stimulating endogenous REC self-activation and mediating crosstalk with other renal cells. We also identified S100A9 as one of the key factors in the SOX9+ REC secretome. Altogether, the abilities to extensively propagate SOX9+ RECs in culture whilst concomitantly maintaining their intrinsic secretory capacity suggest their future application in cell-free therapies and regeneration medicine.
Cao C, Memete O, Dun Y, Zhang L, Liu F, He D Stem Cell Res Ther. 2025; 16(1):13.
PMID: 39849583 PMC: 11756119. DOI: 10.1186/s13287-024-04124-1.
Li J, Chen L, Wang Y, Kang M, Liang S, Hong X Acta Pharmacol Sin. 2025; .
PMID: 39775504 DOI: 10.1038/s41401-024-01445-y.
Traditional Chinese Medicine and renal regeneration: experimental evidence and future perspectives.
Zhang D, Jiang H, Yang X, Zheng S, Li Y, Liu S Chin Med. 2024; 19(1):77.
PMID: 38831435 PMC: 11149241. DOI: 10.1186/s13020-024-00935-9.
Advances and potential of regenerative medicine in pediatric nephrology.
Slaats G, Chen J, Levtchenko E, Verhaar M, Oliveira Arcolino F Pediatr Nephrol. 2023; 39(2):383-395.
PMID: 37400705 PMC: 10728238. DOI: 10.1007/s00467-023-06039-0.
Li J, Gong X Front Pharmacol. 2023; 14:1101036.
PMID: 37153766 PMC: 10157647. DOI: 10.3389/fphar.2023.1101036.